Grants Grants

1.    National Center of Science: 2022/45/B/NZ5/01973: Molecular and cellular mechanisms responsible for the initiation and progression of clear cell renal cell carcinoma (K. Miękus)

2.    National Center of Science: 2022/47/B/NZ5/02724: The significance of Zc3h12a gene deletion in hepatocytes and proximal tubular epithelial cells for neoplastic transformation and sorafenib resistance (P. Marona)

3.    National Center of Science: 2022/47/D/NZ3/01654: Are MCPIP1 and MCPIP3 analogous or opposite players in the maintenance of skin function? (A. Lichawska-Cieślar)

4.    National Center of Science: 2021/42/E/NZ5/00169: Role of Mcpip1 in biliary pathobiology: new potential therapeutic opportunities (J. Kotlinowski)

5.    National Center of Science: 2021/41/B/NZ5/03601: The role of PIN domain containing proteins in regulation of non-coding RNAs. (J.Jura)

6.    National Center of Science: 2021/41/N/NZ5/01832: Regulatory role of miRNAs and modification of β-catenin in the metastatic potential of clear cell renal cell carcinoma. (J. Górka)

7.    National Center of Science: 2021/41/N/NZ4/04187: Interplay between sex hormones and hepatocellular carcinoma progression in mice model. (O. Kwapisz)

8.    National Center of Science: 2020/37/B/NZ4/02533: Exploring the mechanisms of therapy-facilitated metastasis and CAAX proteins-processing enzymes in liver cancer. (J. Cisowski)

9.    National Center of Science: 2020/37/N/NZ5/00575: MCPIP1 as a regulator of skin homeostasis. (W. Szukała)

10.    Polpharma Scientific Foundation: Jerzy Kotlinowski: Analysis of MCPIP1 protein function in the etiology and development of primary cholangitis in mice – clinical implications. (J. Kotlinowski)

11.    National Center of Science: 2017/26/E/NZ5/00691: Regulation of epithelial to mesenchymal transition and therapy resistance to antitumor therapies by MCPIP1. (K. Miękus)


Completed research grants:

12.    National Center of Science: 2017/27/B/NZ5/01440: The role of MCPIP1 RNase in disrupted endothelial homeostasis accompanying non-alcoholic fatty liver disease. (J. Kotlinowski)

13.    National Center of Science: 2019/33/N/NZ5/00916: Explanation of antifibrotic role of Mcpip1 in the liver.   (N.Pydyn)

14.    National Center of Science: 2017/25/N/NZ5/03014: The role of MCPIP1 as a potential tumor suppressor during development and treatment of clear cell renal cell carcinoma. (P. Marona)

15.    National Center of Science: 2016/23/B/NZ3/00792: Role of MCPIP1 protein in epidermis physiology and pathophysiology. (J. Jura)

16.    National Center of Science: 2016/21/D/NZ6/01003:  The function of the RNA-binding protein HuR in IL-17-associated severe astma. (T. Herjan)

17.    National Center of Science: 2015/19/B/NZ5/01405: The role of MCPIP1 protein in growth, progression and vascularisation of clear cell renal cell carcinoma (K. Miękus)

18.    National Center of Science: 2015/19/D/NZ5/00254: MCPIP1 as an important regulator of development and progression of non-alcoholic fatty liver disease. (J. Kotlinowski)

19.    National Center of Science: 2015/17/B/NZ3/01051: Structure analysis and identification of templates degraded by Regnase-1. (J. Jura)

20.   National Center of Science: 2014/13/N/NZ3/00729: The role of MCPIP1 RNase in proliferation and differentiation of primary human keratinocytes (P. Konieczny)

21.    National Center of Science: 2013/11/B/NZ2/00125: Identification of transcripts degraded by regnase 1 and their significance in adipogenesis (J. Jura)

22.   National Center of Science: 2013/09/D/NZ5/00249: Molecular analysis of clear cell renal cell carcinoma progression in the context of the search for predictive factors prior to treatment (K. Miękus)